NOVEL APOC-I ISOFORMS AND THEIR USE AS BIOMARKERS AND RISK FACTORS OF ATHEROSCLEROTIC DISEASE
    3.
    发明申请
    NOVEL APOC-I ISOFORMS AND THEIR USE AS BIOMARKERS AND RISK FACTORS OF ATHEROSCLEROTIC DISEASE 审中-公开
    新型APOC-I ISOFORMS及其作为生物标志物和ATHEROSCLEROTIC DISEASE的风险因素

    公开(公告)号:US20140193846A1

    公开(公告)日:2014-07-10

    申请号:US14112670

    申请日:2011-12-23

    IPC分类号: G01N33/92

    摘要: Novel isoforms of apolipoprotein C-I (apoC-I), namely apolipoprotein C-I1 (apoC-I1) and apolipoprotein C-I1′ (apoC-I1′), both of which have a molecular weight of approximately 90 daltons greater than native apolipoprotein C-I (SEQ ID NO:6) and native apolipoprotein C-I′ (SEQ ID NO:7), are shown to be both biomarkers for diagnosing atherosclerotic disease as well as risk factors for subjects having increased risk of developing an atherosclerotic disease.

    摘要翻译: 载脂蛋白C1(apoC-I),即载脂蛋白C-I1(apoC-I1)和载脂蛋白C-I1'(apoC-I1')的新型同工型,其分子量比天然载脂蛋白CI大约为90道尔顿 (SEQ ID NO:6)和天然载脂蛋白C1'(SEQ ID NO:7)显示为用于诊断动脉粥样硬化疾病的生物标志物以及具有发展动脉粥样硬化疾病风险增加的受试者的危险因素。